Dermadry Launches 5th Annual Hyperhidrosis Scholarship: $2,000 Cash Prize for Students With Excessive Sweating

2 years ago

Dermadry is back with its fifth annual edition of the Dermadry Hyperhidrosis Scholarship. The contest is open to students who…

Empower Clinics Announces Closing of Second Tranche Private Placement Financing

2 years ago

VANCOUVER, BC / ACCESSWIRE / August 15, 2023 / Empower Clinics Inc. ("Empower" or the "Company") (CSE:EPW)(OTC PINK:EPWCF), is pleased…

Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates

2 years ago

REDWOOD CITY, CA / ACCESSWIRE / August 15, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS)…

Vytalize Health Named No. 71 on Inc. 5000 List of America’s Fastest-Growing Companies

2 years ago

The company landed in the top 10 for Healthcare Services on Inc. Magazine's 2023 list following its remarkable growth and…

FSD Pharma Selected to Present its Phase 1 Data on Lucid-MS at MSMilan 2023 – 9th Joint ECTRIMS-ACTRIMS Meeting for October 11-13, 2023

2 years ago

Targeting the Approximate $22 Billion Multiple Sclerosis Drug Treatment MarketTORONTO, ON / ACCESSWIRE / August 15, 2023 / FSD Pharma…

National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

2 years ago

BOULDER, CO / ACCESSWIRE / August 15, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing…

Leading Provider of On-Demand Medical Equipment & Services for Hospitals, US Med-Equip, Secures Spot on Inc. 5000 Fastest-Growing Company List for the 11th Time

2 years ago

HOUSTON, TX / ACCESSWIRE / August 15, 2023 / US Med-Equip, a leading provider of on-demand medical equipment solutions, earned…

Fuse Medical, Inc. Announces Second Quarter 2023 Financial Results

2 years ago

RICHARDSON, Texas, Aug. 15, 2023 (GLOBE NEWSWIRE) -- On August 14, 2023, Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the…

Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development

2 years ago

FORT LEE, N.J., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and…